Assenagon Asset Management S.A. Boosts Holdings in UFP Technologies, Inc. (NASDAQ:UFPT)

Assenagon Asset Management S.A. increased its position in shares of UFP Technologies, Inc. (NASDAQ:UFPT) by 340.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 39,304 shares of the industrial products company’s stock after purchasing an additional 30,372 shares during the quarter. Assenagon Asset Management S.A.’s holdings in UFP Technologies were worth $9,610,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the business. Wasatch Advisors LP increased its stake in UFP Technologies by 65.4% during the third quarter. Wasatch Advisors LP now owns 420,549 shares of the industrial products company’s stock worth $133,188,000 after acquiring an additional 166,262 shares during the last quarter. Eagle Asset Management Inc. acquired a new stake in shares of UFP Technologies during the 3rd quarter worth about $9,791,000. Franklin Resources Inc. raised its holdings in UFP Technologies by 39.4% in the 3rd quarter. Franklin Resources Inc. now owns 92,053 shares of the industrial products company’s stock valued at $28,904,000 after buying an additional 26,001 shares during the period. De Lisle Partners LLP lifted its position in UFP Technologies by 30.6% in the third quarter. De Lisle Partners LLP now owns 66,573 shares of the industrial products company’s stock valued at $21,070,000 after buying an additional 15,603 shares during the last quarter. Finally, Millennium Management LLC boosted its stake in UFP Technologies by 78.8% during the second quarter. Millennium Management LLC now owns 26,706 shares of the industrial products company’s stock worth $7,047,000 after buying an additional 11,767 shares during the period. 87.28% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at UFP Technologies

In other UFP Technologies news, Director Cynthia L. Feldmann sold 647 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $352.30, for a total value of $227,938.10. Following the completion of the transaction, the director now owns 4,049 shares of the company’s stock, valued at $1,426,462.70. This trade represents a 13.78 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO R Jeffrey Bailly sold 12,533 shares of the business’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $346.46, for a total transaction of $4,342,183.18. Following the completion of the transaction, the chief executive officer now owns 31,194 shares of the company’s stock, valued at approximately $10,807,473.24. This trade represents a 28.66 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,326 shares of company stock valued at $4,620,154 in the last three months. 6.17% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of UFP Technologies from a “sell” rating to a “hold” rating in a research note on Wednesday.

UFP Technologies Trading Up 1.1 %

Shares of NASDAQ UFPT opened at $265.04 on Friday. The company has a current ratio of 2.57, a quick ratio of 1.43 and a debt-to-equity ratio of 0.64. The stock has a market capitalization of $2.03 billion, a PE ratio of 37.81 and a beta of 1.04. UFP Technologies, Inc. has a twelve month low of $152.43 and a twelve month high of $366.41. The stock has a fifty day simple moving average of $275.61 and a 200-day simple moving average of $299.98.

UFP Technologies Company Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.